Ripudaman S Beniwal, MD
Gastroenterology · Manteca
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 34 years
- Graduated 1992
Offices
1 location
Hospitals listed: Doctors Hospital of Manteca · Sutter Tracy Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Beniwal’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A67409 · Current
Licensed to practise in California · since 1999 · expires 2026-11-30 · University of Rajasthan, S. M. S. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Doctors Hospital of MantecaManteca, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 55% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
- Sutter Tracy Community HospitalTracy, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Doctors Hospital of Manteca
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 230 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.49 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 700 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.1 to 0.56) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,462 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.24 to 6.39) · 137 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.57 to 4) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,152 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 67.3 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 60 · 183 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.4 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.2 to 16.8) · 379 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (339 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 56% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 55% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Sutter Tracy Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 2 better, 5 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 363 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 156 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.6 · 51 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 835 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,800 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,820 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.09 (0.6 to 5.57) · 291 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 138 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 274 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (0 to 17.04) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.93 (0.72 to 9.15) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 26 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.981 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 194 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -47.9 · 145 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.1 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.3 to 16.7) · 504 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 104 cases | No different | Jan 2024 – Dec 2024 |
What patients said (443 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$133,590
Medicare paid this office $133,590 for 601 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 317 | $34,833 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 151 | $28,121 | $186 |
| New patient visit (45+ min) | 204 | $21,473 | $105 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 55 | $10,046 | $183 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $9,246 | $88 |
See all 12 services
| Return visit (30+ min) | 317 | $34,833 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 151 | $28,121 | $186 |
| New patient visit (45+ min) | 204 | $21,473 | $105 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 55 | $10,046 | $183 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $9,246 | $88 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 51 | $6,025 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,370 | $104 |
| Biopsy of large bowel using a flexible endoscope | 24 | $3,753 | $156 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $3,556 | $142 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $3,485 | $145 |
| Long return visit (40+ min) | 14 | $1,624 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $755 | $63 |
Procedures Medicare counted
| Colonoscopy | 237 | More than 95% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 202 | More than 90% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 102 | 68 | 142 | 146 | 138 | 151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 115 | 54 | 106 | 91 | 99 | 105 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 86 | 54 | 91 | 66 | 49 | 56 |
| Biopsy of large bowel using a flexible endoscope | 68 | 24 | 33 | 22 | 23 | 24 |
| Diagnostic exam of large bowel using a flexible endoscope | 32 | 13 | 33 | 27 | 18 | 25 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | 13 | 20 | 35 | 23 | 24 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
601 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 9% · Women 55% · Also on Medicaid 20% · Health risk score 1.38. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 39% · Chronic kidney disease 32% · Depression 21% · Heart failure 20% · COPD 19% · Atrial fibrillation 17% · Cancer 15% · Stroke 11% · Dementia 5%.
The office billed $671,878, Medicare allowed $170,855 and paid $133,590; for 1,205 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 601 | 1,205 | 74 | 1.38 | $671,878 | $133,590 |
| 2023 | 566 | 1,089 | 74 | 1.26 | $629,378 | $118,023 |
| 2022 | 607 | 1,229 | 74 | 1.27 | $682,029 | $132,528 |
| 2021 | 560 | 1,299 | 73 | 1.49 | $703,716 | $138,280 |
| 2020 | 482 | 969 | 74 | 1.47 | $424,100 | $88,317 |
| 2019 | 704 | 1,427 | 73 | 1.50 | $724,088 | $149,018 |
| 2018 | 678 | 1,432 | 72 | 1.42 | $704,600 | $151,446 |
| 2017 | 690 | 1,666 | 73 | 1.52 | $855,142 | $163,672 |
| 2016 | 695 | 1,612 | 72 | 1.54 | $772,234 | $166,935 |
| 2015 | 612 | 1,485 | 72 | 1.49 | $702,244 | $157,994 |
| 2014 | 638 | 1,555 | 72 | 1.33 | $782,887 | $177,240 |
| 2013 | 731 | 1,653 | 71 | 1.21 | $912,478 | $205,162 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 278 | $27,120 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 138 | $26,426 | $191 |
| New patient visit (45+ min) | 138 | $13,978 | $101 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 98 | $8,331 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 62 | $6,986 | $106 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 35 | $6,396 | $183 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 46 | $5,186 | $106 |
| Biopsy of large bowel using a flexible endoscope | 23 | $3,422 | $149 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $3,381 | $147 |
| Control of bleeding of upper large bowel using a flexible endoscope | 16 | $3,030 | $189 |
| New patient visit (30+ min) | 47 | $2,867 | $61 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,667 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $774 | $65 |
2022: 13 services
| Return visit (30+ min) | 315 | $30,395 | $73 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 145 | $28,859 | $198 |
| New patient visit (45+ min) | 145 | $15,599 | $108 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 88 | $7,781 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 66 | $7,437 | $109 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 65 | $6,513 | $99 |
| New patient visit (30+ min) | 99 | $6,476 | $65 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 30 | $5,628 | $188 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $5,563 | $159 |
| Diagnostic exam of large bowel using a flexible endoscope | 26 | $3,829 | $142 |
| Biopsy of large bowel using a flexible endoscope | 22 | $3,231 | $147 |
| Control of bleeding of upper large bowel using a flexible endoscope | 12 | $2,525 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,100 | $58 |
2021: 14 services
| Return visit (30+ min) | 314 | $36,945 | $78 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 142 | $28,130 | $198 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 87 | $9,778 | $107 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $9,099 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 76 | $9,072 | $109 |
| New patient visit (30+ min) | 96 | $6,247 | $65 |
| New patient visit (45+ min) | 56 | $5,841 | $102 |
| Biopsy of large bowel using a flexible endoscope | 33 | $5,292 | $160 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $4,592 | $191 |
| Diagnostic exam of large bowel using a flexible endoscope | 31 | $4,570 | $138 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $3,232 | $162 |
| Short return visit (20+ min) | 42 | $2,173 | $48 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,102 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,355 | $59 |
2020: 13 services
| Return visit (30+ min) | 163 | $13,960 | $76 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 67 | $13,771 | $203 |
| Short return visit (20+ min) | 173 | $10,257 | $41 |
| New patient visit (30+ min) | 112 | $7,220 | $64 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 48 | $6,580 | $122 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $6,272 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | $4,781 | $89 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 23 | $4,359 | $190 |
| Biopsy of large bowel using a flexible endoscope | 24 | $3,611 | $150 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,198 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,984 | $60 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $1,958 | $151 |
| New patient visit (45+ min) | 11 | $1,106 | $101 |
2019: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 102 | $21,231 | $208 |
| Short return visit (20+ min) | 256 | $20,064 | $58 |
| Return visit (30+ min) | 171 | $18,034 | $88 |
| New patient visit (30+ min) | 206 | $16,703 | $81 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 58 | $11,186 | $193 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 113 | $10,840 | $94 |
| Biopsy of large bowel using a flexible endoscope | 68 | $10,790 | $159 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 82 | $9,847 | $115 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 82 | $9,237 | $111 |
| Diagnostic exam of large bowel using a flexible endoscope | 31 | $4,706 | $147 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $3,446 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,127 | $59 |
2018: 15 services
| Return visit (30+ min) | 232 | $25,790 | $83 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 101 | $20,336 | $199 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 70 | $13,399 | $191 |
| New patient visit (30+ min) | 160 | $12,746 | $80 |
| Short return visit (20+ min) | 183 | $11,655 | $54 |
| Biopsy of large bowel using a flexible endoscope | 61 | $9,842 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 84 | $9,813 | $110 |
| New patient visit (45+ min) | 75 | $9,342 | $125 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 67 | $8,828 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 91 | $7,525 | $83 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,207 | $191 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $3,752 | $150 |
| Long return visit (40+ min) | 26 | $2,831 | $109 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,423 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,766 | $59 |
2017: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 118 | $24,141 | $201 |
| Short return visit (20+ min) | 284 | $22,840 | $55 |
| New patient visit (30+ min) | 216 | $17,557 | $81 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 81 | $15,367 | $190 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 118 | $14,167 | $110 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 195 | $12,307 | $62 |
| Return visit (30+ min) | 98 | $8,904 | $79 |
| Biopsy of large bowel using a flexible endoscope | 57 | $8,806 | $154 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 68 | $7,377 | $107 |
| Diagnostic exam of large bowel using a flexible endoscope | 29 | $3,831 | $128 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $3,273 | $164 |
| New patient visit (45+ min) | 23 | $2,812 | $122 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,687 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,226 | $59 |
| New patient visit (15+ min) | 38 | $2,082 | $55 |
| Incision of pancreatic outlet using a flexible endoscope | 12 | $1,156 | $96 |
| Short return visit | 21 | $685 | $33 |
2016: 14 services
| Return visit (30+ min) | 213 | $24,408 | $83 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 99 | $21,127 | $209 |
| New patient visit (30+ min) | 192 | $16,159 | $84 |
| Short return visit (20+ min) | 218 | $15,561 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 190 | $13,643 | $70 |
| Biopsy of large bowel using a flexible endoscope | 68 | $11,416 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 91 | $10,782 | $109 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 69 | $9,173 | $122 |
| Diagnostic exam of large bowel using a flexible endoscope | 53 | $8,056 | $149 |
| New patient visit (45+ min) | 60 | $7,389 | $123 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 37 | $7,336 | $198 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $2,761 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,754 | $58 |
| New patient visit (15+ min) | 31 | $1,721 | $56 |
2015: 14 services
| Return visit (30+ min) | 234 | $25,258 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 82 | $19,126 | $233 |
| Short return visit (20+ min) | 248 | $17,235 | $56 |
| Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare tehnique | 64 | $16,438 | $257 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 177 | $11,234 | $61 |
| New patient visit (45+ min) | 85 | $11,017 | $130 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 76 | $8,978 | $109 |
| Biopsy of large bowel using a flexible endoscope | 41 | $7,726 | $188 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 37 | $7,680 | $208 |
| Diagnostic exam of large bowel using a flexible endoscope | 45 | $7,629 | $162 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $7,552 | $106 |
| New patient visit (30+ min) | 74 | $6,199 | $84 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,886 | $157 |
| Short return visit | 19 | $644 | $34 |
2014: 15 services
| Return visit (30+ min) | 216 | $24,964 | $84 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 103 | $24,292 | $234 |
| Removal of polyps or growths in large bowel using an endoscope | 79 | $20,427 | $259 |
| New patient visit (30+ min) | 190 | $16,033 | $84 |
| Short return visit (20+ min) | 188 | $14,138 | $57 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 170 | $11,737 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 103 | $11,638 | $109 |
| Diagnostic exam of large bowel using a flexible endoscope | 70 | $11,232 | $160 |
| Biopsy of large bowel using a flexible endoscope | 55 | $9,435 | $168 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $8,296 | $754 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 59 | $7,614 | $119 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $3,738 | $163 |
| New patient visit (45+ min) | 21 | $2,821 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,105 | $55 |
| Short return visit | 31 | $1,075 | $35 |
2013: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 112 | $26,636 | $238 |
| Return visit (30+ min) | 218 | $23,945 | $80 |
| New patient visit (30+ min) | 300 | $22,957 | $77 |
| Removal of polyps or growths in large bowel using an endoscope | 90 | $22,451 | $249 |
| Imaging of digestive tract done from the inside of the digestive tract | 24 | $19,178 | $799 |
| Diagnostic exam of large bowel using a flexible endoscope | 101 | $15,997 | $155 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 200 | $15,880 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 75 | $8,141 | $103 |
| Biopsy of large bowel using a flexible endoscope | 47 | $7,719 | $164 |
| Short return visit (20+ min) | 115 | $7,509 | $54 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 66 | $7,023 | $106 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 32 | $6,823 | $213 |
| New patient visit (45+ min) | 35 | $4,355 | $124 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $3,455 | $216 |
| Long return visit (40+ min) | 20 | $2,066 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,893 | $158 |
| Short return visit | 13 | $286 | $22 |
Medicaid work
$2,194 in 2024
Medicaid paid $2,194 for 45 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 16 | $1,479 |
| Return visit (30+ min) | 29 | $715 |
| 2024 | 45 | 2 | 16 | $2,194 |
| 2023 | 53 | 1 | 16 | $2,015 |
| 2022 | 12 | 1 | 12 | $508 |
| 2021 | 37 | 1 | 13 | $1,770 |
| 2020 | 28 | 1 | 15 | $1,192 |
| 2019 | 27 | 2 | 13 | $1,735 |
| 2018 | 12 | 1 | 12 | $975 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 53 | $2,015 |
2022
| Return visit (30+ min) | 12 | $508 |
2021
| Return visit (30+ min) | 37 | $1,770 |
2020
| Return visit (30+ min) | 28 | $1,192 |
2019
| New patient visit (30+ min) | 13 | $947 |
| Return visit (30+ min) | 14 | $788 |
2018
| Return visit (30+ min) | 12 | $975 |
Drugs they prescribed that Part D paid
$320,511
Pharmacies billed $320,511 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,609) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,268 generic and fewer than 11 brand-name prescriptions · $320,511 in drug cost · 43 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira | 13 | $90,734 | $6,980 |
| Sod Sulf-Potass Sulf-Mag Sulf | 460 | $29,682 | $65 |
| Creon | 27 | $25,442 | $942 |
| Linzess | 20 | $11,856 | $593 |
| Mesalamine | 21 | $11,307 | $538 |
See all 24 drugs
| Humira | 13 | $90,734 | $6,980 |
| Sod Sulf-Potass Sulf-Mag Sulf | 460 | $29,682 | $65 |
| Creon | 27 | $25,442 | $942 |
| Linzess | 20 | $11,856 | $593 |
| Mesalamine | 21 | $11,307 | $538 |
| Sucralfate | 135 | $9,555 | $71 |
| Omeprazole | 208 | $2,379 | $11 |
| Famotidine | 144 | $2,073 | $14 |
| Ursodiol | 22 | $1,797 | $82 |
| Sulfasalazine | 51 | $1,603 | $31 |
| Cholestyramine | 22 | $1,417 | $64 |
| Esomeprazole Magnesium | 27 | $1,262 | $47 |
| Pantoprazole | 80 | $1,088 | $14 |
| Budesonide Ec | 11 | $888 | $81 |
| Azathioprine | 17 | $866 | $51 |
| Constulose | 14 | $563 | $40 |
| Lansoprazole | 21 | $465 | $22 |
| Dicyclomine | 19 | $462 | $24 |
| Gavilyte-G | 24 | $414 | $17 |
| Ondansetron Odt | 13 | $149 | $11 |
| Metronidazole | 15 | $102 | $7 |
| Prednisone | 13 | $70 | $5 |
| Spironolactone | 19 | $67 | $4 |
| Propranolol | 11 | $40 | $4 |
Year by year
| 2024 | 1,609 | 688 | 0% (0) | None | $320,511 |
| 2023 | 1,385 | 606 | 0% (0) | 26% | $243,974 |
| 2022 | 1,284 | 540 | 0% (0) | 33% | $163,641 |
| 2021 | 1,322 | 470 | None | None | $190,348 |
| 2020 | 1,193 | 362 | 0% (0) | 24% | $246,959 |
| 2019 | 1,330 | 534 | 0% (0) | 25% | $109,984 |
| 2018 | 1,394 | 519 | None | 28% | $284,174 |
| 2017 | 1,427 | 525 | 0% (0) | 26% | $148,563 |
| 2016 | 1,624 | 576 | None | None | $130,364 |
| 2015 | 1,386 | 500 | None | 26% | $133,823 |
| 2014 | 1,377 | 500 | None | None | $153,247 |
| 2013 | 1,496 | 527 | None | None | $127,392 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Sod Sulf-Potass Sulf-Mag Sulf | 295 | $23,318 | $79 |
| Creon | 17 | $21,689 | $1,276 |
| Linzess | 23 | $16,758 | $729 |
| Sucralfate | 112 | $5,971 | $53 |
| Vancomycin | 12 | $2,849 | $237 |
| Omeprazole | 218 | $2,814 | $13 |
| Sutab | 12 | $1,981 | $165 |
| Ursodiol | 21 | $1,923 | $92 |
| Famotidine | 115 | $1,817 | $16 |
| Esomeprazole Magnesium | 26 | $1,530 | $59 |
| Sulfasalazine | 48 | $1,478 | $31 |
| Azathioprine | 13 | $1,461 | $112 |
| Gavilyte-G | 75 | $1,396 | $19 |
| Suprep | 12 | $1,230 | $103 |
| Balsalazide Disodium | 15 | $1,132 | $75 |
| Lansoprazole | 31 | $1,129 | $36 |
| Constulose | 12 | $859 | $72 |
| Dicyclomine | 21 | $836 | $40 |
| Cholestyramine | 15 | $743 | $50 |
| Pantoprazole | 48 | $637 | $13 |
| Peg-3350 and Electrolytes | 17 | $305 | $18 |
| Lactulose | 11 | $218 | $20 |
| Prednisone | 13 | $113 | $9 |
| Spironolactone | 11 | $87 | $8 |
2022: 20 drugs
| Suprep | 198 | $21,799 | $110 |
| Sucralfate | 141 | $11,373 | $81 |
| Linzess | 11 | $6,760 | $615 |
| Sod Sulf-Potass Sulf-Mag Sulf | 82 | $6,451 | $79 |
| Ursodiol | 17 | $4,075 | $240 |
| Vancomycin | 13 | $3,842 | $296 |
| Omeprazole | 262 | $2,625 | $10 |
| Sulfasalazine | 69 | $2,557 | $37 |
| Lansoprazole | 27 | $2,169 | $80 |
| Cholestyramine | 16 | $1,714 | $107 |
| Famotidine | 102 | $1,306 | $13 |
| Balsalazide Disodium | 11 | $855 | $78 |
| Esomeprazole Magnesium | 11 | $767 | $70 |
| Lactulose | 21 | $752 | $36 |
| Dicyclomine | 27 | $661 | $24 |
| Pantoprazole | 24 | $576 | $24 |
| Gavilyte-G | 28 | $385 | $14 |
| Peg-3350 and Electrolytes | 18 | $232 | $13 |
| Ciprofloxacin | 16 | $106 | $7 |
| Metronidazole | 13 | $72 | $6 |
2021: 22 drugs
| Xifaxan | 12 | $37,584 | $3,132 |
| Suprep | 206 | $22,590 | $110 |
| Pentasa | 17 | $21,791 | $1,282 |
| Zenpep | 11 | $8,303 | $755 |
| Linzess | 11 | $6,946 | $631 |
| Sucralfate | 116 | $6,913 | $60 |
| Omeprazole | 303 | $2,855 | $9 |
| Ursodiol | 19 | $2,347 | $124 |
| Sulfasalazine | 83 | $2,292 | $28 |
| Esomeprazole Magnesium | 14 | $1,851 | $132 |
| Lansoprazole | 44 | $1,615 | $37 |
| Famotidine | 90 | $1,512 | $17 |
| Cholestyramine | 15 | $1,413 | $94 |
| Azathioprine | 27 | $1,227 | $45 |
| Balsalazide Disodium | 11 | $871 | $79 |
| Pantoprazole | 56 | $758 | $14 |
| Peg-3350 and Electrolytes | 26 | $355 | $14 |
| Peg 3350-Electrolyte | 11 | $202 | $18 |
| Gavilyte-G | 18 | $201 | $11 |
| Dicyclomine | 14 | $190 | $14 |
| Ondansetron | 16 | $168 | $10 |
| Metronidazole | 18 | $78 | $4 |
2020: 20 drugs
| Xifaxan | 13 | $32,814 | $2,524 |
| Pentasa | 22 | $30,501 | $1,386 |
| Suprep | 95 | $10,014 | $105 |
| Zenpep | 15 | $8,852 | $590 |
| Ursodiol | 22 | $5,046 | $229 |
| Vancomycin | 12 | $4,792 | $399 |
| Sucralfate | 100 | $4,741 | $47 |
| Sulfasalazine | 85 | $3,513 | $41 |
| Omeprazole | 288 | $3,025 | $11 |
| Esomeprazole Magnesium | 28 | $2,895 | $103 |
| Cholestyramine | 23 | $2,420 | $105 |
| Azathioprine | 23 | $2,088 | $91 |
| Famotidine | 86 | $1,191 | $14 |
| Lansoprazole | 58 | $1,165 | $20 |
| Pantoprazole | 37 | $622 | $17 |
| Gavilyte-G | 41 | $527 | $13 |
| Dicyclomine | 25 | $394 | $16 |
| Prednisone | 13 | $159 | $12 |
| Metronidazole | 17 | $94 | $6 |
| Ciprofloxacin | 11 | $25 | $2 |
2019: 22 drugs
| Suprep | 140 | $14,054 | $100 |
| Mesalamine | 13 | $8,071 | $621 |
| Dexilant | 14 | $6,292 | $449 |
| Ursodiol | 11 | $4,021 | $366 |
| Omeprazole | 263 | $2,887 | $11 |
| Esomeprazole Magnesium | 30 | $2,744 | $91 |
| Sulfasalazine | 50 | $2,708 | $54 |
| Sucralfate | 93 | $2,690 | $29 |
| Lansoprazole | 62 | $2,602 | $42 |
| Gavilyte-G | 115 | $1,603 | $14 |
| Azathioprine | 19 | $1,258 | $66 |
| Cholestyramine | 25 | $1,186 | $47 |
| Famotidine | 80 | $1,017 | $13 |
| Pantoprazole | 58 | $709 | $12 |
| Dicyclomine | 41 | $617 | $15 |
| Lactulose | 12 | $453 | $38 |
| Amitriptyline | 21 | $343 | $16 |
| Metoclopramide | 21 | $214 | $10 |
| Peg-3350 and Electrolytes | 14 | $157 | $11 |
| Metronidazole | 22 | $130 | $6 |
| Ranitidine | 11 | $109 | $10 |
| Ciprofloxacin | 17 | $52 | $3 |
2018: 24 drugs
| Suprep | 176 | $16,412 | $93 |
| Linzess | 19 | $11,537 | $607 |
| Zenpep | 15 | $9,428 | $629 |
| Mesalamine | 12 | $4,824 | $402 |
| Ursodiol | 11 | $4,473 | $407 |
| Sucralfate | 91 | $2,946 | $32 |
| Lansoprazole | 76 | $2,893 | $38 |
| Sulfasalazine | 65 | $2,656 | $41 |
| Omeprazole | 229 | $2,483 | $11 |
| Esomeprazole Magnesium | 20 | $2,432 | $122 |
| Gavilyte-G | 94 | $1,146 | $12 |
| Polyethylene Glycol 3350 | 53 | $1,044 | $20 |
| Azathioprine | 18 | $816 | $45 |
| Famotidine | 48 | $638 | $13 |
| Rabeprazole | 17 | $576 | $34 |
| Pantoprazole | 42 | $519 | $12 |
| Metoclopramide | 46 | $408 | $9 |
| Loperamide | 14 | $373 | $27 |
| Amitriptyline | 16 | $342 | $21 |
| Metronidazole | 42 | $322 | $8 |
| Dicyclomine | 30 | $313 | $10 |
| Peg-3350 and Electrolytes | 22 | $234 | $11 |
| Prochlorperazine Maleate | 11 | $68 | $6 |
| Ciprofloxacin | 16 | $65 | $4 |
2017: 23 drugs
| Uceris | 13 | $23,264 | $1,790 |
| Linzess | 29 | $12,883 | $444 |
| Suprep | 136 | $11,928 | $88 |
| Lialda | 12 | $10,834 | $903 |
| Zenpep | 21 | $8,473 | $403 |
| Ursodiol | 20 | $6,775 | $339 |
| Esomeprazole Magnesium | 25 | $4,397 | $176 |
| Sulfasalazine | 96 | $3,294 | $34 |
| Sucralfate | 93 | $2,429 | $26 |
| Omeprazole | 248 | $2,130 | $9 |
| Lansoprazole | 39 | $1,885 | $48 |
| Gavilyte-G | 121 | $1,665 | $14 |
| Rabeprazole | 15 | $1,591 | $106 |
| Polyethylene Glycol 3350 | 69 | $1,347 | $20 |
| Azathioprine | 23 | $947 | $41 |
| Peg-3350 and Electrolytes | 46 | $566 | $12 |
| Dicyclomine | 45 | $494 | $11 |
| Pantoprazole | 33 | $471 | $14 |
| Famotidine | 57 | $426 | $7 |
| Metoclopramide | 40 | $394 | $10 |
| Metronidazole | 23 | $156 | $7 |
| Ciprofloxacin | 15 | $91 | $6 |
| Prochlorperazine Maleate | 12 | $53 | $4 |
2016: 29 drugs
| Lialda | 16 | $11,522 | $720 |
| Linzess | 18 | $9,446 | $525 |
| Dexilant | 31 | $8,767 | $283 |
| Suprep | 91 | $7,525 | $83 |
| Nexium | 21 | $7,465 | $355 |
| Ursodiol | 28 | $6,621 | $236 |
| Carafate | 15 | $4,459 | $297 |
| Flovent Hfa | 11 | $4,021 | $366 |
| Esomeprazole Magnesium | 13 | $3,325 | $256 |
| Lansoprazole | 69 | $2,926 | $42 |
| Omeprazole | 315 | $2,766 | $9 |
| Sulfasalazine | 99 | $2,491 | $25 |
| Gavilyte-G | 138 | $2,023 | $15 |
| Rabeprazole | 16 | $1,944 | $122 |
| Proctosol-Hc | 22 | $1,510 | $69 |
| Sucralfate | 83 | $1,501 | $18 |
| Polyethylene Glycol 3350 | 68 | $1,392 | $20 |
| Mercaptopurine | 12 | $1,285 | $107 |
| Peg-3350 and Electrolytes | 86 | $1,151 | $13 |
| Dicyclomine | 58 | $551 | $10 |
| Azathioprine | 13 | $537 | $41 |
| Pantoprazole | 40 | $496 | $12 |
| Metoclopramide | 46 | $406 | $9 |
| Spironolactone | 21 | $341 | $16 |
| Metronidazole | 33 | $306 | $9 |
| Famotidine | 20 | $193 | $10 |
| Prochlorperazine Maleate | 22 | $179 | $8 |
| Amoxicillin | 13 | $92 | $7 |
| Ranitidine | 11 | $74 | $7 |
2015: 26 drugs
| Pentasa | 13 | $20,178 | $1,552 |
| Lialda | 16 | $10,555 | $660 |
| Dexilant | 28 | $9,420 | $336 |
| Suprep | 97 | $7,813 | $81 |
| Nexium | 15 | $5,240 | $349 |
| Ursodiol | 14 | $4,340 | $310 |
| Lansoprazole | 80 | $3,916 | $49 |
| Carafate | 16 | $3,252 | $203 |
| Omeprazole | 304 | $2,991 | $10 |
| Sulfasalazine | 63 | $1,899 | $30 |
| Sucralfate | 68 | $1,706 | $25 |
| Gavilyte-G | 109 | $1,519 | $14 |
| Rabeprazole | 14 | $1,025 | $73 |
| Polyethylene Glycol 3350 | 44 | $745 | $17 |
| Clarithromycin | 13 | $648 | $50 |
| Peg-3350 and Electrolytes | 47 | $643 | $14 |
| Proctosol-Hc | 13 | $508 | $39 |
| Dicyclomine | 41 | $477 | $12 |
| Metronidazole | 34 | $300 | $9 |
| Pantoprazole | 24 | $276 | $11 |
| Metoclopramide | 27 | $219 | $8 |
| Spironolactone | 13 | $140 | $11 |
| Famotidine | 12 | $114 | $9 |
| Amoxicillin | 18 | $98 | $5 |
| Prochlorperazine Maleate | 13 | $94 | $7 |
| Ciprofloxacin | 17 | $85 | $5 |
2014: 29 drugs
| Pentasa | 11 | $16,266 | $1,479 |
| Canasa | 17 | $11,678 | $687 |
| Nexium | 30 | $11,360 | $379 |
| Suprep | 124 | $9,608 | $77 |
| Lialda | 16 | $9,114 | $570 |
| Aciphex | 14 | $5,780 | $413 |
| Lansoprazole | 57 | $3,857 | $68 |
| Omeprazole | 310 | $3,759 | $12 |
| Amitiza | 11 | $2,081 | $189 |
| Sulfasalazine | 69 | $1,979 | $29 |
| Cholestyramine | 22 | $1,650 | $75 |
| Sucralfate | 56 | $1,411 | $25 |
| Peg-3350 and Electrolytes | 86 | $1,352 | $16 |
| Ursodiol | 13 | $1,184 | $91 |
| Moviprep | 13 | $1,025 | $79 |
| Gavilyte-G | 57 | $879 | $15 |
| Polyethylene Glycol 3350 | 24 | $766 | $32 |
| Pantoprazole | 29 | $422 | $15 |
| Sulfazine | 27 | $348 | $13 |
| Dicyclomine | 33 | $301 | $9 |
| Trilyte With Flavor Packets | 14 | $295 | $21 |
| Proctosol-Hc | 12 | $279 | $23 |
| Metronidazole | 22 | $223 | $10 |
| Famotidine | 11 | $116 | $11 |
| Metoclopramide | 26 | $113 | $4 |
| Peg 3350-Electrolyte | 11 | $113 | $10 |
| Amoxicillin | 13 | $91 | $7 |
| Promethazine | 12 | $84 | $7 |
| Propranolol | 12 | $69 | $6 |
2013: 28 drugs
| Nexium | 48 | $15,906 | $331 |
| Pentasa | 11 | $14,819 | $1,347 |
| Canasa | 17 | $10,416 | $613 |
| Suprep | 108 | $7,864 | $73 |
| Lansoprazole | 84 | $7,394 | $88 |
| Aciphex | 15 | $6,305 | $420 |
| Welchol | 34 | $5,125 | $151 |
| Omeprazole | 314 | $4,962 | $16 |
| Lialda | 12 | $4,670 | $389 |
| Peg-3350 and Electrolytes | 161 | $2,485 | $15 |
| Carafate | 12 | $2,072 | $173 |
| Sulfasalazine | 64 | $2,061 | $32 |
| Sucralfate | 50 | $1,828 | $37 |
| Halflytely-Bisacodyl | 25 | $1,684 | $67 |
| Polyethylene Glycol 3350 | 43 | $1,076 | $25 |
| Pantoprazole | 36 | $433 | $12 |
| Metronidazole | 38 | $419 | $11 |
| Sulfazine | 22 | $290 | $13 |
| Spironolactone | 13 | $272 | $21 |
| Peg-3350 With Flavor Packs | 12 | $238 | $20 |
| Gavilyte-G | 14 | $226 | $16 |
| Gavilyte-C | 14 | $207 | $15 |
| Dicyclomine | 34 | $207 | $6 |
| Famotidine | 20 | $140 | $7 |
| Peg 3350-Electrolyte | 12 | $136 | $11 |
| Diphenoxylate-Atropine | 13 | $78 | $6 |
| Metoclopramide | 11 | $67 | $6 |
| Ciprofloxacin | 12 | $55 | $5 |
Money from drug and device companies
$15 in 2025
| 2025 | 1 | 1 | None | $15 |
| 2024 | 1 | 1 | None | $22 |
| 2021 | 1 | 1 | None | $12 |
| 2019 | 1 | 2 | None | $27 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aimmune Therapeutics | Zenpep | $15 | 1 payment
|
See the published payment
| Aimmune Therapeutics | Meals · 2025-06-17 | Zenpep | $15 |
See earlier years (2024, 2021, 2019)
2024: $22
| Takeda Pharmaceuticals U.S.A. | Entyvio | $22 | 1 payment
|
2021: $12
| Boston Scientific | Lux Dx | $12 | 1 payment
|
2019: $27
| Allergan | Linzess | $27 | 2 payments
|
Checkups this office reported
2 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Patients can see their records onlinePatients who were given electronic access to their health information | 99%That's most of the people this applied to. | 556 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 95%That's most of the people this applied to. | 499 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- ONC-ACB Surveillance Attestation
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Reports to a public-health or clinical registry
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1528039799
- Licence
- CA A67409California A67409: Current · expires 2026-11-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A674090
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1144 Norman Dr Ste 101, Manteca, CA, 95336
- NPI first listed
- 2006-01-27
- NPI last updated
- 2008-10-14
This is when the NPI record was last certified, not a medical board exam.